|
|
|
| A study on the association between type 2 diabetes mellitus (T2DM) combined with non-alcoholic fatty liver disease and serum adiponectin |
| FAN Shi-hong, MAO Yu-shan, MAI Yi-feng
|
| Ningbo University, Ningbo, Zhejiang, 315040, China |
|
|
|
|
Abstract Objective To explore the association between type 2 diabetes mellitus (T2DM) combined with non-alcoholic fatty liver disease (NAFLD) and serum adiponectin (APN) and its clinical significance. Methods A total of 76 patients who were initially diagnosed with T2DM or had been diagnosed with T2DM for less than three years and admitted to the endocrine department and its outpatient clinic of the Affiliated Hospital of Medical School of Ningbo University from August 2011 to July 2013 were selected as the subjects, and were assigned to group A or B, each consisting of 38 patients, based on the presence or absence of associated NAFLD. Another 30 healthy subjects receiving physical examination were assigned to the control group (NC group). The indicators including body mass index (BMI), blood lipids, blood glucose, liver function, insulin resistance index (HOMA-IR) and serum APN, were measured and compared among the groups. Results In group A , the indicators including BMI, triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), alanine aminotransferase (ALT), fasting insulin (FINS) and HOMA-IR were significantly higher than those in group B and NC group, and the APN level was significantly lower than that in group B and NC group (P＜0.05). Pearson correlation analysis indicated that APN was negatively correlated with BMI, TG, high density lipoprotein-cholesterol(HDL-C), and HOMA-IR, and positively correlated with TC, LDL-C and ALT(P＜0.05).Multiple linear regression analysis suggested that HDL-C and HOMA-IR was the independent influencing factors for APN (P＜0.05).Conclusion Severe insulin resistance and glucose and lipid metabolic disorders are present in T2DM patients combined with NAFLD, and adiponectin level is of vital significance for the development and progression of NAFLD.
|
|
Received: 17 February 2016
Published: 20 December 2017
|
|
|
|
|
|
[1]孙霞,汪大望,徐海燕,等. 2 型糖尿病并发非酒精性脂肪肝患者血清内脂素、脂联素水平变化及其临床意义[J].浙江实用医学,2013,18(2):82-84.
[2]谢子一,冉慧,丁艳霞. 2 型糖尿病伴非酒精性脂肪肝患者血清脂联素水平的变化[J].河南医学研究,2014,23(5):37-39.
[3]王丹,刘晓芳,张莹.瘦素和脂联素检测对非酒精性脂肪肝的临床意义[J].实用医技杂志,2014,21(5):518.
[4]TROMBETTA M, SPIAZZI G, ZOPPINI Q, et al. Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study [J].Alimentary Pharmacology and therapeutics,2005,22(2):24-27.
[5]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝诊断标准(2010年修订版)[J].中国肝脏病杂志(电子版),2010,15(11):676-680.
[6]于江红,王慧君.血清脂联素水平与2型糖尿病、胰岛素抵抗的关系[J].武汉大学学报(医学版),2012,33(5):697-699.
[7]李宗军,范佳清,胡晟. 2型糖尿病患者血清脂联素与脂肪肝的相关性[J].河北医学杂志,2012,18(5):600-602.
[8]宋新文,申宝生,王宏伟.非酒精性脂肪性肝病患者血清脂联素与瘦素水平变化[J].实用肝脏病杂志,2013,16(2):141-143.
[9]陈辉,于健,周玲,等.2型糖尿病合并非酒精性脂肪肝患者颈动脉内膜中层厚度与脂联素的相关性[J].中国慢性病预防与控制,2012,20(1):54-56.
[10]华春芬,王飞,叶小君.成人2型糖尿病危险因素的现况研究[J].浙江预防医学,2015,27(1):25-27,31.
[11]曾长佑,胡志勇,孙慧丽,等.丽水市农村2型糖尿病患者社区干预不同方式效果评价[J].浙江预防医学,2015,27(11):1084-1089.
[12]陈涛,王中心,黄丽华,等.初诊2型糖尿病合并高血压患者血清脂联素和改良稳态模型评估法计算的胰岛素抵抗指数的变化及相关性[J].中国高血压杂志,2015,23(5):452-456.
[13]FERREIRA VERA S G, PERNAMBUCO R B, LOPES E P, et al.Frequency and risk factors associated with non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus[J]. Arq Bras Endocrinol Metab,2010, 54(4): 362-368.
[14]张晓,孙丽荣,李明珍.2型糖尿病合并非酒精性脂肪性肝病患者血清高分子量脂联素水平变化[J].中国医学创新,2013,10(9):5-7.
[15]杨帆.合并肥胖的2型糖尿病患者血清脂联素水平与胰岛素抵抗的相关性分析[J].实用临床医药杂志,2015,19(11):161-163.
[16]尚祥岭.脂联素与2型糖尿病及糖尿病早期肾病的临床关联研究[J].中国实用医药,2015,10(21):85-86.
[17]单云华,王丽宏,车慧,等.脂联素在2型糖尿病心血管并发症中的保护作用[J].东南大学学报(医学版),2015,34(2):295-298.
[18]RODINA A V, SEVERIN S E. The role of adiponectin in the pathogenesis of the metabolic syndrome and approach to therapy[J]. Patol Fiziol Eksp Ter,2013(1):15-26.
[19]HANDA P, MALIKEN B D, NELSON J E, et al. Reduced adiponectin signaling due to weight gain results in nonalcoholic steatohepatitis through impaired mitochondrial biogenesis[J]. Hepatology,2014,60(1):133-145.
[20]闫泰山,刘杰.NAFLD儿童瘦素与脂联素检测的临床意义研究[J].中国妇幼健康研究,2014,25(5):793-794.
[21]胡淑芳,左湘川,荣太梓.内脂素和脂联素与2型糖尿病代谢综合征的相关性研究[J].检验医学与临床,2015,12(11):1612-1613. |
|
|
|
